Publications:

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors.

Cell Reports. Medicine

Portelinha, Ana A; Thompson, Scott S; Smith, Roger A RA; Da Silva Ferreira, Mariana M; Asgari, Zahra Z; Knezevic, Andrea A; Seshan, Venkatraman V; de Stanchina, Elisa E; Gupta, Sandeep S; Denis, Louis L; Younes, Anas A; Reddy, Sanjeeva S

Publication Date: 2021-07-20

Variant appearance in text: HER2: Y1248D

PubMed Link: 34337566

Variant Present in the following documents:

• mmc2.pdf

View BVdb publication page

Assessment of computational methods for predicting the effects of missense mutations in human cancers.

Bmc Genomics

Gnad, Florian F; Baucom, Albion A; Mukhyala, Kiran K; Manning, Gerard G; Zhang, Zemin Z

Publication Date: 2013

Variant appearance in text: ERBB2: Y1248D

PubMed Link: 23819521

Variant Present in the following documents:

• 1471-2164-14-S3-S7-S1.xlsx, sheet 1

View BVdb publication page